Protein kinases must recognize their proper target substrates and regulators from among a large number of proteins in the cell 1 . How specificity is achieved is a critical question, given the prominent role of phosphorylation in signal transduction and the misregulation of kinase activity in disease 2 . In the cell cycle, CDKs process signals that lead to cell division 3 . Hundreds of CDK substrates have been identified in proteomic screens, and CDK phosphorylation alters the location, interactions, stability and activity of these target proteins 4, 5 . A deregulated cell cycle is a hallmark of cancer, thus emphasizing the need for tight coordination of CDK activity 6 . Still, many questions remain regarding how regulatory proteins recognize CDKs and how CDKs discriminate among substrates to phosphorylate them in the appropriate order and at the appropriate times in the cell cycle.
Protein kinases must recognize their proper target substrates and regulators from among a large number of proteins in the cell 1 . How specificity is achieved is a critical question, given the prominent role of phosphorylation in signal transduction and the misregulation of kinase activity in disease 2 . In the cell cycle, CDKs process signals that lead to cell division 3 . Hundreds of CDK substrates have been identified in proteomic screens, and CDK phosphorylation alters the location, interactions, stability and activity of these target proteins 4, 5 . A deregulated cell cycle is a hallmark of cancer, thus emphasizing the need for tight coordination of CDK activity 6 . Still, many questions remain regarding how regulatory proteins recognize CDKs and how CDKs discriminate among substrates to phosphorylate them in the appropriate order and at the appropriate times in the cell cycle.
The CDK complex is composed of the kinase subunit, the cyclin subunit and Cks. The active site of the kinase recognizes a mini mum consensus sequence of (S/T)P and an optimal consensus of (S/T)PX(R/K) 7 . In addition to activating the kinase domain, the cyclin subunit binds docking sequences present in some substrates and confers specificity [8] [9] [10] . Although Cks is essential for viability, and its deregulated expression correlates with tumorigenesis and poor cancer prognosis, its particular molecular functions have been less clear [11] [12] [13] [14] [15] [16] [17] . Genetic analysis has shown that Cks genes regulate cell growth and division 11, 12, 15 . In addition to binding CDK and influ encing kinase function, Cks has been implicated in other cellular pro cesses such as transcription and the degradation of the CDK inhibitor p27 (refs. 18-21) .
Several studies have suggested that Cks associates with phospho rylated cell cycle-regulator proteins and has a role in CDK multisite phosphorylation. Multisite phosphorylation is critical for producing proper signaling output [22] [23] [24] [25] [26] [27] , because it influences properties such as sensitivity and switchlike behavior and permits integration of a large number of inputs to produce diverse outputs [28] [29] [30] [31] . Entry into mito sis, for example, is a switchlike transition, and multisite phosphor ylation of the mitotic regulators Wee1 and Cdc25 is critical for this behavior 23, 24, 26, 32, 33 . Similarly, multisite phosphorylation of Sic1 in budding yeast generates an ultrasensitive response for Sphase entry 22, 25 . Different signaling behaviors are generated by differences in enzyme mechanism such as degree of cooperativity and processivity of substrate processing 30 . Therefore, uncovering mechanistic details of how CDK acts on multisite substrates is important for understand ing the molecular origins of highly complex, vastly tunable signaling through phosphorylation.
A role for Cks in binding phosphorylated substrates was postu lated after structures of Cks revealed a conserved cationic pocket that weakly binds free phosphate and other anions 34, 35 . When Cks is bound to CDK, structural modeling suggests that this cationic pocket is part of a continuous surface including the CDK active site and cyclin 36 . In the specific context of the Skp2-Skp1-Cullin ubiq uitin ligase, human Cks1 binds phosphorylated p27 to stimulate its ubiquitylation and degradation 37 . From these structural insights, it has been proposed that Cks binds CDK substrates primed by initial phosphorylation and facilitates further phosphorylation of the primed substrate. This hypothesis is supported by experiments that show that phosphorylation of cell cycle-regulatory proteins is reduced when Cks is immunodepleted from Xenopus egg extracts 38 . We found that semiprocessive phosphorylation of the G1S regulator Sic1 depends on an intact Cks cationic pocket 25 . However, it has not been clari fied whether the stimulatory role of Cks on CDK activity relies on 1 4 0 8 VOLUME 20 NUMBER 12 DECEMBER 2013 nature structural & molecular biology a r t i c l e s specific priming sites or whether any site can prime the multisite phosphorylation reaction.
We demonstrate here that Cks recognizes specific phosphorylated sequences in CDK substrates, uncovering a new mechanism for CDK substrate targeting, CDK interactions with its regulators and signaling kinetics. We identify a Cksbinding consensus sequence and charac terize the complex with a phosphopeptide-Cks crystal structure. Cks interaction with the consensus sequence is required for efficient mul tisite phosphorylation of a subset of CDK substrates and for budding yeast viability. Using the Cks consensus sequence as a search motif, we identify new Cksbinding proteins and demonstrate a critical role for Cks in facilitating Wee1 regulation of CDK at mitotic entry.
RESULTS

Cks binds to specific phosphorylated sites in CDK substrates
A number of phosphorylationdependent CDK-substrate complexes have been reported 23, 39 , and we and others have demonstrated that Cks binds to phosphorylated sequences in intrinsically disordered domains of several CDK substrates 25, 40 . To test whether Cks binds spe cific phosphorylated sites, we examined the affinity of Saccharomyces cerevisiae Cks (Cks1) for the Nterminal domain of the replication licensing factor Cdc6. As determined by isothermal titration calor imetry (ITC), Cks1 binds to phosphorylated (phos) Cdc6 with K d = 9.8 ± 0.2 µM, whereas no detectable heat was measured for the unphosphorylated protein (Fig. 1a) . The pres ence of two distinct and independent Cks1 binding sites in phosCdc6 is supported by the stoichiometry parameter; the data fit to a onesite model with n ≈2, thus indicating that two molecules of Cks1 bind noncooperatively to each phosphorylated Cdc6 molecule.
We then mutated different combinations of phosphoacceptor sites and found that Cks1 binds to Cdc6 1-48 phosphorylated only at T7 and T23 (Cdc6 1-48;T39A S43A ) with a similar affinity and stoichiometry as fully phosphor ylated Cdc6 (Fig. 1b and Supplementary  Fig. 1 ). In contrast, we observed no detect able binding signal with Cdc6 phosphor ylated only at T39 and S43. Cdc6 constructs in which only T7 (Cdc6 1-48;T23A T39A S43A ) or T23 (Cdc6 1-48;T7A T39A S43A ) are phospho rylated bind with similar affinity as for the wildtype protein but have stoichiometries of n ≈1. We also tested binding of Cks1 to synthetic peptides, phosCdc 2-10 and pho sCdc6 [19] [20] [21] [22] [23] [24] [25] [26] , which contain only phosphor ylated T7 or T23 respectively. Each bound to Cks1 with an affinity about tenfold less than that of phosphorylated Cdc . A Cdc6 construct in which T7 and T23 are mutated to alanine and the sequence surrounding T39 is replaced with the T7 sequence (Cdc6 1-48;T7T39swap ) binds Cks1 with wildtype affinity. We conclude that the majority of the cohe sive interactions are contained within short sequences including the phosphothreonines and suggest that the peptides bind with slightly lower affinity, owing to a greater entropy penalty. Together, these data demonstrate that T7 or T23 phosphorylation is necessary and suf ficient for Cks1 association and that Cks1 has binding requirements beyond the minimum phosphorylated (S/T)P CDK site.
We tested the minimum sequence around T7 required for binding Cks1, using a dotblot assay. We crosslinked synthetic phosphopep tides to BSA, spotted them onto a PVDF membrane and then incub ated the membrane with hexahistidinetagged Cks1 and probed it with an antihexahistidine antibody (Fig. 2a) . We found that the heptapeptides AIPIpTPT and IPIpTPTK (p, phospho) were suffi cient for Cks1 binding. ITC measurements confirmed that AIPI(pT)P, SAIPI(pT)P and AIPI(pT)PT bind Cks1 with similar affinity as does phosCdc6 [2] [3] [4] [5] [6] [7] [8] [9] [10] (Supplementary Table 1 ). We substituted phospho serine and phosphotyrosine for phosphothreonine and observed no binding to Cks1 in both the dotblot and ITC assays.
In order to identify the Cdc6 sequence determinants of Cks affinity, we used SPOT arrays with peptides directly synthesized on a mem brane (Fig. 2b) . Every spot contains a version of the phosCdc6 3 Supplementary Figure 1a -g. npg a r t i c l e s sequence in which a single substitution is made at each position with each of the 20 amino acids. The array was probed as described above, except Cks1 was alkylated to prevent the formation of disulfide link ages (Supplementary Fig. 2 ). We observed that no residue is tolerated at the pT position (0 position), including the phosphomimetics gluta mate and aspartate, and that proline is required in the +1 position.
These results indicate that all Cks1binding sequences contain the phosphorylated CDK consensus site TP. Cks1 also displays a marked propensity for binding to peptides with a bulky hydrophobic residue in the −2 position. The array demonstrates that any residue is toler ated in the −4, −3, +2 and +3 positions, although a basic residue or proline seems to be disfavored in the +2 position. There appears to be a varied preference in the −1 position; however, there is no clear corre lation between the chemical properties of the tolerated side chains. In order to corroborate that these observations are general for Cks1 binding and are not influenced by subtle effects of the specific Cdc6 3-10 sequence context, we conducted the array based on a sequence in Sic1 (Fig. 2c) . Sic1 T5 is a preferred CDKphosphorylation site that serves as a priming site for Cksdependent phosphorylation 25 . Probing a phosSic1 2-9 array for Cks1 binding, we again found a requirement for phosphothreonine and proline in the 0 and +1 positions, respectively, a preference for a bulky hydrophobic residue in the −2 position and a disfavoring of a positive residue in the +2 position.
We performed ITC with Cks1 and phosCdc6 2-10 peptides to con firm and quantify the SPOT array results (Supplementary Table 1 ). Replacement of the phosphothreonine for a different phosphorylated side chain (pT7pS and pT7pY) or substitution of the +1 proline (P8K) results in loss of detectable heat. Substitutions of aromatic residues for the proline in the −2 position either have little effect or slightly increase binding affinity relative to that of wild type, whereas sub stitution of a charged lysine at the −2 position (P5K) results in no detectable heat. The +2 position in the SPOT array disfavored a posi tive charge or proline. However, by ITC, we found that substitution of a proline (T9P) or a lysine (T9K) for the +2 threonine results in a binding affinity similar to that of wildtype peptide.
Three CDK sites (T5, T33 and T45) in the Sic Nterminal domain (Sic1 1-215 , 'Sic1∆C') facilitate Cks binding 10 , and these sites are known to promote primingdependent phosphorylation 25 . T5 and T45 contain a proline in the −2 position, and their phosphoryla tion promotes higheraffinity binding to Cks compared to that of the binding promoted by phosphorylation of T33, which contains a glutamate in the −2 position 10 . We measured affinity for wild type and substituted phosSic1 2-9 peptides (Supplementary Table 1 ). PhosSic1 2-9 binds with a slightly weaker affinity (K d = 95 ± 8 µM) than does the entire phosphorylated Sic1 N terminus and phosSic1∆C that contains only T5 as a phosphoacceptor site (K d = 11 ± 3 µM and K d = 20 ± 10 µM, respectively 10, 25 ). As in the case of Cdc6, this observation suggests an interaction between the immediate sequence surrounding T5 and Cks1. The affinities of phosSic1 2-9 peptides with single amino acid substitutions show the same trend as for the Cdc6 peptides (Supplementary Table 1 ). The ITC measurements are also consistent with the SPOT array data, with the exception that a positive lysine is tolerated in the +2 position in the ITC measurements.
Structural basis of Cks binding specificity
We next determined the 2.9Å crystal structure of a Cks1-phosCdc6 complex to understand the molecular determinants of the specificity observed in our binding experiments ( Table 1 and Fig. 3 ). Crystals were grown from a fusionprotein construct, phosphorylated after purification, in which the Cdc6 3-9 sequence was appended to the C terminus of Cks1 (Supplementary Fig. 3 ). The Cdc6 sequence binds across a surface of Cks1 that is distal to the CDKbinding site and is made up of one face of the Cks1 βsheet and helix 2 (Fig. 3a) . The phosphate on the Cdc6 T7 side chain is bound to the previously described cationic pocket (Fig. 3b) 34, 35 . The Cdc6 T7 γmethyl makes van der Waals contacts with Y30 and R42 in Cks1; this explains the specificity for phosphothreonine over phosphoserine. Cdc6 P8, which npg a r t i c l e s is in the +1 position, fits into a pocket formed by both Y30 and T80 in Cks1. That no other hydrophobic residues are tolerated in this +1 position suggests that geometry constraints in the Cdc6 backbone are important for proline specificity. The dihedral angles adopted by the +1 proline (Φ ≈ −80, ψ ≈ −160) to contact Y30 and T80 are rela tively disfavored by other residues. The loss of affinity upon proline substitution probably arises from the compromise of maintaining the side chain-Cks1 contacts and adopting such strained torsion angles. The γhydroxyl of Cks1 T80 acts as a hydrogenbond donor to the backbone carbonyl of I6 (−1 position) in Cdc6. Although there is no clear correlation among the chemical properties of the tolerated amino acids at the −1 position in the array data (Fig. 2b,c) , this hydro gen bond may select for particular backbone dihedral preferences that best facilitate its formation. A second pocket formed by Cks L83 and R75 fits Cdc6 P5 (the −2 position). The distances to the −2 proline side chain explain the preference for a large hydrophobic residue in this position. The presence of R75, which is highly conserved in Cks proteins, is also consistent with the observed preference for aromatic residues in the −2 position of the binding consensus sequence (Fig. 2b,c) , because the guanidinium group is capable of making cationπ interactions with aromatic side chains 41 . There are few interactions in the crystal structure between Cks1 and residues in the +2, +3 and −3 positions in the Cdc6 peptide, results consistent with our observation that any amino acid type can substitute there.
We verified the importance of the molecular interactions observed in the crystal structure of the Cks1-phosCdc6 complex with single amino acid mutations in Cks1, purifying Y30E, R75A, R75K, T80D and L83D Cks1 mutants and testing them for binding to phosCdc6 by ITC. The structure shows that Y30 and T80 are important for binding the +1 proline, whereas R75 and L83 form the pocket to accommodate the −2 proline. All the mutants were folded properly, as determined by CD (Supplementary Fig. 4a) . As predicted by the structure, mutations at these positions inhibited binding to the phosCdc6 2-10 peptide in the calorimetry assay; in each case, no heat was detected (Supplementary Fig. 1z-dd) .
Priming-dependent CDK activity requires Cks-substrate binding
We next explored the implications of Ckssubstrate docking for its function in stimulating CDK activity toward cellcycle substrates. We previously found that priming phosphorylation of Sic1 facilitates semiprocessive phosphorylation of critical phosphodegrons, and the requirement for an intact Cks1 cationic pocket demonstrated the importance of Cksdependent kinetics for CDK signaling 25 .
The structural details of the Cks-substrate complex observed here allowed us to test specifically the effect of disrupting this complex on CDK kinetics. We tested whether Cks1 mutations that abolish interactions with substrate residues inhibit multisite phosphoryla tion (Fig. 4) . As previously described 25 , we added recombinant Cks1 to Cdk1-Clb5 purified from budding yeast and used the enzyme to phosphorylate the noninhibitory truncation Sic1∆C in a kinase assay. In the reaction with wildtype Cks1, hyperphosphorylated species are present within 8 min and are the dominant product (Fig. 4a) . Previous substratecompetition experiments established that the rapid accumulation of these hyperphosphorylated forms is due to a semi processive mechanism 25 . In contrast, hyperphosphorylated Sic1∆C does not appear in the same reaction time upon addition of Cks1 with mutations to the phosphatebinding pocket ('+pocket' , R33E S82E R102A) or a Y30E mutation. Stronger bands corresponding to hypophosphorylated forms are instead present. Use of R75A, T80D and L83D mutants also results in considerable loss of hyperphospho rylated Sic1∆C, and intermediate forms containing fewer phosphates are the dominant product. All the mutants are capable of forming a complex with CDK (Supplementary Fig. 4b ). In reactions with a Sic1∆C containing a single phosphorylation site (i.e., all sites mutated to alanine except T5), the mutants behave similarly to wildtype Cks1 (Fig. 4a) . This control reaction demonstrates that Cks1 mutations that disrupt substrate docking have no effect on the catalytic activity of the kinase toward a single phosphoacceptor site but instead result in defects specifically in the mechanism of multisite phosphorylation.
To demonstrate directly the function of Cks in primingdependent phosphorylation, we assayed kinase activity on primed substrates (Fig. 4b,c) . We synthesized a Cdc6 2-29 peptide with T7 as a phospho threonine. We then measured the steadystate kinetics of phosphate incorporation at T23 in the presence of the phosphorylated T7. The K m for the kinase reaction using Cdk1-Clb5 and wildtype Cks1 is less than that measured for a generic singlesite substrate or Sic1 with a single T5 phosphoacceptor site available (Supplementary Fig. 5) . Conversely, the absolute k cat value for the wildtype reaction, calculated in these experiments by comparison of V max to the published absolute k cat for the H1 peptide 9 , is similar to the k cat for reactions with singlesite sub strates. We tested, in similar reactions, Cks1 that contains mutations in the consensus sequence-binding residues (Fig. 4b) . These reactions all proceed with K m values greater than those for reactions with wildtype protein. As observed in the Sic1∆C multisite phosphorylation assay, mutations in the cationic pocket or Y30 have the largest effect on K m , whereas the T80D, L83D and R75A mutations all show clear but more modest effects. These data demonstrate that Cks1 residues critical for We also assayed the importance of the Cksbinding consensus sequence in the substrate. We synthesized Cdc6 peptides with muta tions in the phosphoacceptor site or in surrounding consensus resi dues and used them in kinase reactions with wildtype Cks1 (Fig. 4c) . Mutation of the priming phosphothreonine to an alanine (T7A) leads to a K m increase for the reaction measuring phosphate incor poration at T23. Mutation of the proline in the −2 position of the consensus site to a tyrosine (P5Y) does not change the K m from the wildtype reaction, whereas mutation to a lysine (P5K) increases the K m by threefold, results consistent with our binding measurements. Mutation of the +1 proline (P8A) results in a sixfold increase in K m . These results together further establish the importance of the Ckssubstrate association for enhancing CDK multisite kinetics and demonstrate that a binding consensus, and not solely a phosphate, directs the primingdependent reaction.
To demonstrate the importance of Cks1 association with specific primingsite sequences in vivo, we examined the viability of Cks1 mutants that are defective in consensussequence binding in bud ding yeast (Fig. 4d) . We identified a mutation (L98S) in Cks1 that has temperature sensitivity at 34 °C. At the restrictive temperature, growth is impaired, as described previously 12 , but is rescued by wildtype Cks1 expressed from a CEN vector and under control of the alco hol dehydrogenase promoter. In contrast, expression of a phosphate binding-pocket mutant or the consensus sequence-binding mutants fails to rescue the temperature sensitivity.
The Cks-binding consensus is present in a subset of CDK substrates
To find CDK substrates that associate with Cks, we considered the sequence (F/I/L/P/V/W/Y)XTP, which contains the minimum requirements for binding Cks1, on the basis of our data. We inputted this sequence into the Yeast Genome Database Pattern Matching tool (http://www.yeastgenome.org/cgibin/PATMATCH/nphpatmatch/) and found that 3,263 sequences match the consensus; these sequences are found in 2,100 different open reading frames (ORFs) (Fig. 5a) . 269 of the 2,100 ORFs are known CDK substrates, as determined in at least one of the two global CDKsubstrate identification studies 4, 5 . There are 522 putative Cksbinding sequences within these 269 ORFs (listed in Supplementary Table 2) .
In order to filter and characterize better the properties of Cks tar gets, we further analyzed the 522 putative Cksbinding sites found in CDK substrates (Fig. 5) . We first searched for evidence validating that the sites are phosphorylated by CDK or other kinases. 48 of the 522 sites were identified as CDKphosphorylation sites in an MSbased proteomics screen to identify CDK substrates (Fig. 5a ) 5 , and 42 other CDK sites tend to be found in regions of proteins that lack struc ture 5, 42 . We analyzed whether the Cks consensus sites are in sequences that are likely to be structured or disordered, using a webbased dis order prediction tool 43 . We found that 309 of the 522 putative Cks sites (59%) are in regions of likely disorder, whereas 73 of the 90 (81%) Cks sites that are verified phosphorylation sites are found in likely disordered regions (Fig. 5b) . When all putative Cks sites are con sidered, there is no significant preference for disordered sequences; however, the statistics for the subset of Cks sites corresponding to verified phosphorylation sites do suggest that Cks preferentially binds unstructured sequences. The disorder frequency of Cks sites is less than the disorder frequency (99%) of all verified CDK sites in the MS screen 5 . It may be that Cks sites are more likely to be found in predicted structured regions because of the hydrophobic amino acid in the −2 position.
Considering the role of Cks in stimulating multisite phosphoryla tion kinetics, we predicted and found that Cks sites preferentially occur in substrates that contain multiple CDK sites. Putative Cks sites that are verified phosphorylation sites occur in substrates with more than one CDK site at a frequency that is greater than expected from the multiplicity distribution of all CDK substrates found in the MS screen (Fig. 5c) 5 .
Cks mediates Cdk1-directed Wee1 activity at mitotic entry
In examining the list of putative Cks binding partners, we found the potential docking association of Cks1 with budding yeast Wee1 (called Swe1) to be of particular interest because Swe1 is known to form a phosphorylationdependent complex with Cdk1 during mitotic entry. This complex is required for efficient inhibitory phosphorylation of Cdk1 by Swe1 on Y19 (refs. 23, 32, 33) . Formation of the complex requires phosphorylation of eight consensus sites in Wee1 by Cdk1 (ref. 33) . Similar mechanisms are likely to act in vertebrate cells 32, 44, 45 . We hypothesized that Cks docking to specific phosphorylated consen sus sites mediates the Cdk1-Wee1 complex, and we tested this idea with mutational analysis of Swe1 in budding yeast.
Of the eight consensus Cdk1 phosphosites in Swe1, there are four phosphothreonines: T45, T121, T196 and T373. All except T45 pos sess a bulky hydrophobic residue in the −2 position, and T196 and T373 were previously found to have an important role in Cdk1 complex formation in budding yeast 33 . Although neither the precise sequences surrounding the sites nor their location in the primary sequence is conserved in higher eukaryotes, most Swe1 orthologs contain three or four putative Cksbinding sites. We tested Cks1 binding to each of these phosphopeptides by ITC and found, as predicted, that all except T45 bound Cks1 with an affinity similar to that between phosCdc6 2-10 and Cks1 (Supplementary Table 1) . To assay the importance of the Cksbinding sites in vivo, we con structed a yeast strain in which the three consensus threonines in 5 for all CDK substrates found in that screen (red) and for substrates that contain putative Cks sequences that are also verified phosphorylation sites (purple). The substrates that contain zero verified CDK sites in the MS screen contain Cks sequences that are phosphorylated according to the PhosphoGRID database. The P value is calculated for a distribution between either zero or one CDK sites or more than one CDK site (i.e., n = 2, with n describing the number of categories into which the data were binned). The χ 2 test was used, assuming an expected distribution for the Cks-containing proteins that is equivalent to the distribution for all verified CDK sites in the MS screen. npg a r t i c l e s Swe1 were mutated to serines (T121S T196S T373S; 'triple mutant') and in which Cdk1 phosphorylation of Swe1 is preserved, but Cks association is inhibited. We observed no considerable difference in the phosphorylation pattern of mutant and wildtype Swe1 (Fig. 6) after release from G1 arrest, results suggesting that the Cks consensus sites do not have a role in Swe1 hyperphosphorylation in vivo. The triple mutant cells do show a defect in phosphorylation of Cdk1 on Y19 (Fig. 6) . The decreased Cdk1 phosphorylation is not due to reduced Swe1, because the total amount of Swe1 and its phosphorylation state are consistent between mutant and wildtype cells (Fig. 6) . We con clude that the Cks consensus sites are critical for Swe1 activity toward Cdk1. That hyperphosphorylation of Swe1 appears to be normal in the mutant suggests that Cks1 binding does not influence multisite phosphorylation in this context. Rather, Cks1 mediates formation of the complex in response to phosphorylation of the Cks1 consensus site, and this in turn allows Swe1 to phosphorylate Cdk1 efficiently on its inhibitory site.
DISCUSSION
Although it has been postulated that Cks stimulates CDK activity by binding primed substrates 3, 13 , little evidence has been provided for this model, and the association of Cks with phosphorylated substrates has not been well characterized. We demonstrate here that Cks binds phosphorylated CDK substrates in a sequencedependent manner and find that efficient hyperphosphorylation of substrates depends on recognition of sequence elements that surround the phosphate.
Our results support a model in which Cks binds specific priming sites to facilitate phosphorylation at other sites (Fig. 7a) . Other data suggest that Cks1 orients substrates for CDK phosphorylation at sites that are C terminal to the Cks1binding site 10 . Characterization of the Cksbinding consensus sequence has permitted identification of a large set of CDK substrates (269 proteins containing 522 Cks sites) that may use the Cksdependent hyperphosphorylation mecha nism. Considering that a smaller subset of putative Cksbinding sites contains sites for which phosphorylation has been directly observed (90 sites in 70 proteins), we anticipate that the actual number of Cksinteracting substrates in the cell is more modest. It remains an open question how many real Cksdirected CDK substrates exist, and it will be interesting to explore the different cellcycle contexts in which Cks contributes to the desired signaling response. The observation that only a subset of CDK sites have the required surrounding sequence for Cks binding has important implications for the understanding of multisite phosphorylation in cellcycle regula tion. The data presented here and in the accompanying paper dem onstrate that CDK phosphoacceptor sites differentially influence the kinetics of phosphate incorporation at other sites 10 . This regulatory mechanism can be used to control whether and when sites with criti cal outputs are phosphorylated. For example, in Sic1, phosphorylation at specific sites required for ubiquitylation and degradation requires priming phosphorylation at the Cks consensus site 10 . It has also been shown recently that different phosphorylation events in the retino blastoma protein induce distinct conformational changes 27 , and this motivates the need for unique control of phosphorylation at distinct sites. This notion that specific phosphorylation sites have distinct roles in tuning signaling outputs differs from other models for the mechanism of multisite phosphorylation in the cell cycle 22, 24 , in which phosphorylation sites have generic roles.
Our data suggest that the influence of Cks on CDKsubstrate phos phorylation kinetics depends on whether Cksbinding consensus sites are phosphorylated early or late in the multisite reaction. In the case that a Cksbinding site is phosphorylated early, phosphorylation trig gers Cks binding to enhance phosphorylation of the remaining sites (Fig. 7a) . The consensus sequence for optimal Cks1 affinity contains a CDKacceptor site (TP), and this is consistent with a selfpriming mechanism. We note that other kinases could phosphorylate the Cks consensus site, including MAP kinases, which also recognize TP 46 . The scenario depicted in Figure 7a is true for Sic1. Two optimal CDK sites that act as Cksdependent priming (T5 and T33) sites are required for semiprocessive phosphorylation of Sic1 and its degradation 10, 25 . Cdc25 phosphorylation also uses the priming mechanism; mutation of Cks consensus sites abrogates cooperativity in the phosphorylation kinetics 26 . Alternatively, if Cks consensus sites are phosphorylated late in the multisite reaction, CDK phosphorylation proceeds without or with limited Cksinduced stimulation for that particular substrate (Fig. 7b) . Swe1 (Wee1) may be an example of such a substrate. We observe no effect on Swe1 hyperphosphorylation in vivo when the Cks consensus is disrupted, and it has been proposed that the best Cks consensus sites (T196 and T373) are phosphorylated late 33 .
We found that the Cks consensus site in buddingyeast Wee1 is required for its ability to phosphorylate CDK on the inhibitory Y19 site. This observation demonstrates a new role for Cks in regulation of CDK activity through influencing posttranslational modifications and explains one mechanism by which Cks regulates mitotic entry. It also emphasizes that the cellular role of Cks extends beyond its capacity to stimulate CDK kinetics. Cks mediates phosphorylation dependent interactions between CDK and its own regulators (Fig. 7b) . The Wee1-Cdk1 complex is a second example of this func tion, the first example being the binding of human Cks1 (hsCks1) to phosphorylated p27 (phosp27) within a ubiquitin ligase 18, 19 .
The structure of hsCks1 bound to phosp27 in the context of the Skp2-Skp1-Cullin ligase was previously solved 37 , and comparison with the phosCdc6-Cks1 structure here indicates several similari ties (Supplementary Fig. 6 ). The location of the phosphothreonine phosphate and γmethyl groups and contacts with the +1 proline are equivalent. One notable difference is the presence of a gluta mate in the −2 position in phosp27, which is not preferred in the Cks is a specificity factor that mediates CDK-substrate association for multiple functions. (a) Cks binds substrates phosphorylated at specific consensus sites (blue phosphate (P)), and the Cks-CDKsubstrate complex stimulates further phosphorylation. The stimulatory effect requires that the Cks consensus site be phosphorylated early in the reaction, as is true in Sic1.
(b) Cks acts as an adaptor that targets CDK to its regulators. In the case of Wee1, association with Cks consensus sites induces inhibitory phosphorylation in CDK (red phosphate).
npg a r t i c l e s
Cks1binding consensus site. In the phosp27-hsCks1 ligase structure, this phos27 E185 hydrogenbonds with R294 and Y346 of Skp2 and Q52 of hsCks1. In Cks1, L83 is in the equivalent position as Q52. This difference explains why glutamate in the −2 position facilitates the phosp27hsCks1 interaction in the context of ubiquitylation, whereas a hydrophobic residue is required for general Cks1 binding to phosphorylated targets. HsCks2 has a leucine at the hsCks1 Q52 position, similarly to Cks1, the fissionyeast ortholog suc1 and the frog ortholog p9. Our observations suggest that hsCks2, like its more distant orthologs, has a general role in CDK binding to its substrates and regulators, whereas Cks1 has evolved to gain its specific function as an adaptor for the Skp2 SCF ligase. Further dissection of the func tional differences between the human Cks paralogs will be important for understanding the role of Cks in tumorigenesis and for its use as a cancer diagnostic.
METhODS
Methods and any associated references are available in the online version of the paper.
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Coordinates and structure factors for the Cks1 1-112 -phosCdc6 3-9 fusion protein have been deposited in the Protein Data Bank under accession code 4LPA.
